{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:11:28Z","timestamp":1778911888322,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["IMI115672"],"award-info":[{"award-number":["IMI115672"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["601738"],"award-info":[{"award-number":["601738"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["284930"],"award-info":[{"award-number":["284930"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003506","name":"Helse- og Omsorgsdepartementet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jvacx.2019.100029","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T04:07:34Z","timestamp":1561003654000},"page":"100029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination"],"prefix":"10.1016","volume":"2","author":[{"given":"Anders","family":"Madsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Tete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Jane","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sne","family":"Jul-Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.jvacx.2019.100029_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Global Seasonal Influenza-associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvacx.2019.100029_b0010","unstructured":"World Health Organization. Pandemic (H1N1) 2009\u2014update 68. <http:\/\/www.who.int\/csr\/don\/2009_10_02\/en\/> Accessed Aug 10; 2018."},{"key":"10.1016\/j.jvacx.2019.100029_b0015","unstructured":"Helse og omsorgsdepartementet. Beredskap mot pandemisk influensa Meld. St. 16 (2012\u20132013). <https:\/\/www.regjeringen.no\/contentassets\/a7c7e93dbe8f44d2a8fe892768e429c5\/no\/pdfs\/stm201220130016000dddpdfs.pdf> Accessed Sept 27, 2018"},{"issue":"5","key":"10.1016\/j.jvacx.2019.100029_b0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"12","key":"10.1016\/j.jvacx.2019.100029_b0025","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"issue":"198","key":"10.1016\/j.jvacx.2019.100029_b0030","doi-asserted-by":"crossref","first-page":"198ra107","DOI":"10.1126\/scitranslmed.3006637","article-title":"Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis","volume":"5","author":"Miller","year":"2013","journal-title":"Sci Transl Med."},{"issue":"10","key":"10.1016\/j.jvacx.2019.100029_b0035","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.jvacx.2019.100029_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025797","article-title":"H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination","volume":"6","author":"Moody","year":"2011","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.jvacx.2019.100029_b0045","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2019.100029_b0050","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/npjvaccines.2016.1","article-title":"Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination","volume":"1","author":"Tete","year":"2016","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.jvacx.2019.100029_b0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.98.6.641","article-title":"Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus","volume":"98","author":"Davenport","year":"1953","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.jvacx.2019.100029_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002802","article-title":"Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. Basler CF, ed","volume":"8","author":"Lessler","year":"2012","journal-title":"PLoS Pathog"},{"issue":"6313","key":"10.1016\/j.jvacx.2019.100029_b0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","article-title":"Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting","volume":"354","author":"Gostic","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jvacx.2019.100029_b0070","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02091-17","article-title":"Pandemic paradox: early life H2N2 pandemic influenza infection enhanced susceptibility to death during the 2009 H1N1 pandemic","volume":"9","author":"Gagnon","year":"2018","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.jvacx.2019.100029_b0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.vaccine.2010.10.038","article-title":"An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in healthcare workers","volume":"29","author":"Madhun","year":"2010","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.jvacx.2019.100029_b0080","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1016\/j.vaccine.2014.06.009","article-title":"Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination","volume":"32","author":"Pedersen","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jvacx.2019.100029_b0085","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.jvacx.2019.100029_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.jvacx.2019.100029_b0095","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jvacx.2019.100029_b0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/CVI.00396-10","article-title":"Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands","volume":"18","author":"Bodewes","year":"2011","journal-title":"Clin Vaccine Immunol: CVI"},{"issue":"4","key":"10.1016\/j.jvacx.2019.100029_b0105","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hygiene"},{"key":"10.1016\/j.jvacx.2019.100029_b0110","unstructured":"The European Agency for the Evaluation of Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines. <https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/note-guidance-harmonisation-requirements-influenza-vaccines_en.pdf> Accessed August 10, 2018."},{"issue":"6","key":"10.1016\/j.jvacx.2019.100029_b0115","first-page":"2210","article-title":"Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations","volume":"49","author":"Veguilla","year":"2011","journal-title":"J ClinMicrobiol"},{"key":"10.1016\/j.jvacx.2019.100029_b0120","unstructured":"World Health Organization. Pandemic influenza preparedness and response a WHO guidance document. <http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44123\/9789241547680_eng.pdf;jsessionid=81287D7008D080E4432039FF04F145B0?sequence=1>. Accessed August 22, 2018."},{"key":"10.1016\/j.jvacx.2019.100029_b0125","first-page":"197","article-title":"Reduced hospital stay in influenza patients after mass vaccination during the 2009 influenza pandemic in Norway","volume":"4","author":"Mohn","year":"2013","journal-title":"J Vaccines Vaccin"},{"issue":"3","key":"10.1016\/j.jvacx.2019.100029_b0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an adjuvant system containing \u03b1-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"Gar\u00e7on","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.jvacx.2019.100029_b0135","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing \u03b1-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2019.100029_b0140","doi-asserted-by":"crossref","first-page":"37229","DOI":"10.1038\/srep37229","article-title":"Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination","volume":"6","author":"Galson","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jvacx.2019.100029_b0145","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1080\/21645515.2015.1048939","article-title":"Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains","volume":"11","author":"Lartey","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.jvacx.2019.100029_b0150","doi-asserted-by":"crossref","first-page":"e01996","DOI":"10.1128\/mBio.01996-15","article-title":"Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans","volume":"7","author":"Nachbagauer","year":"2016","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.jvacx.2019.100029_b0155","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02284-17","article-title":"Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A\/H1N1pdm virus","volume":"9","author":"Park","year":"2018","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.jvacx.2019.100029_b0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nm.2262","article-title":"Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes","volume":"17","author":"Monsalvo","year":"2011","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jvacx.2019.100029_b0165","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of suc-cessful priming by Haemophilus influenzae type B conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"issue":"9720","key":"10.1016\/j.jvacx.2019.100029_b0170","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(09)62126-7","article-title":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study","volume":"375","author":"Miller","year":"2010","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jvacx.2019.100029_b0175","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jvacx.2019.100029_b0180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.arr.2010.08.004","article-title":"Age effects on B cells and humoral immunity in humans","volume":"10","author":"Frasca","year":"2011","journal-title":"Age Res Rev"},{"issue":"4","key":"10.1016\/j.jvacx.2019.100029_b0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/524146","article-title":"Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?","volume":"197","author":"Skowronski","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jvacx.2019.100029_b0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1189\/jlb.0811427","article-title":"Mechanisms of sex disparities in influenza pathogenesis","volume":"92","author":"Klein","year":"2012","journal-title":"J Leukoc Biol"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136219300300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136219300300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:52:57Z","timestamp":1778910777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136219300300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":38,"alternative-id":["S2590136219300300"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2019.100029","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2019.100029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100029"}}